Assuntos
Colecistocinina/biossíntese , Diabetes Mellitus Experimental/metabolismo , Hipotálamo/metabolismo , Animais , Glicemia/metabolismo , Colecistocinina/farmacologia , Imuno-Histoquímica , Injeções Intraventriculares , Ilhotas Pancreáticas/efeitos dos fármacos , Ilhotas Pancreáticas/metabolismo , Masculino , Ratos , Ratos Wistar , Fatores de TempoAssuntos
Bombesina/farmacologia , Diabetes Mellitus Experimental/fisiopatologia , Ilhotas Pancreáticas/metabolismo , Animais , Glicemia/metabolismo , Bombesina/administração & dosagem , Diabetes Mellitus Experimental/patologia , Injeções Intraperitoneais , Injeções Intraventriculares , Insulina/sangue , Insulina/metabolismo , Secreção de Insulina , Masculino , Ratos , Ratos Wistar , Estimulação QuímicaRESUMO
The investigation was performed in 96 Wistar rats. Diabetes mellitus was induced by single injection of 50 mg/kg of streptozotocin. Cholecystokinin (CCK) synthesizing neurons were identified in hypothalamic structures using indirect immunofluorescence. In latent period of diabetes (2 wks) number of CCK--immunopositive neurons increases, especially in paraventricular and suprachiasmatic nuclei, while in ventrolateral subnucleus of arcuate nucleus and parvicellular subnucleus of paraventricular nucleus areas occupied by immunoreactive material in neurons and their CCK content are reduced. By the end of wk 5 of the disease increase in number of CCK immunopositive neurons was registered only in medial parvicellular subnucleus of paraventricular nucleus whereas in other structures their number was reduced. The administration of CCK to intact animals causes increase of insulin content in endocrinocytes of pancreatic islets, but does not affect the level of hypoglycemia. The administration of the peptide to animals with diabetes leads to destruction of pancreatic islets, decline in endocrinocyte number and insulin content and marked hypoglycemia. Thus, the data obtained indicate the significant role of hypothalamic peptidergic system and CCK in regulation of beta-endocrinocyte function.
Assuntos
Colecistocinina/biossíntese , Diabetes Mellitus Experimental/metabolismo , Hipotálamo/metabolismo , Animais , Colecistocinina/farmacologia , Injeções Intraventriculares , Insulina/metabolismo , Ilhotas Pancreáticas/metabolismo , Ilhotas Pancreáticas/patologia , Masculino , Neurônios/metabolismo , Ratos , Ratos WistarRESUMO
The native sum of valepotriates isolated from Val. alliariifolia Adams which was named valiracyl is an agent of low toxicity and exerts a pronounced neurotropic effect. Valiracyl suppresses the orientation reflex of animals in an "open field", decreases a spontaneous and caffeine-stimulated motor activity, potentiates and prolongs the action of barbiturates, significantly reduces aggressiveness of animals, decreases sensitivity to the convulsant effects of corasol and thiosemicarbazide, produces the antihypoxic and mild myorelaxant actions. The neurotropic effects of valiracyl are related to increased level of the GABA inhibition mediator and decreased intensity of bioenergetic processes in the brain.